<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> is a rare combination of generalised <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> and <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Its clinical presentation varies widely and its aetiology is still not known </plain></SENT>
<SENT sid="2" pm="."><plain>60 to 80% of patients are female </plain></SENT>
<SENT sid="3" pm="."><plain>First symptoms of the syndrome are mostly repetitive cerebral <z:hpo ids='HP_0001297'>strokes</z:hpo>, but reduced perfusion of the skin, seen as blue or red-brown mottling, precedes the <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> is generalised and often accompanied by <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo>, systemic arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The diagnostic procedures are complicated and have to exclude other autoimmunological diseases </plain></SENT>
<SENT sid="6" pm="."><plain>Therapeutic options are anticoagulatory therapy with <z:chebi fb="8" ids="10033">warfarin</z:chebi>, ASS or <z:chebi fb="5" ids="28304">heparin</z:chebi>, reduction of endothelial proliferation with <z:chebi fb="2" ids="35457">ACE-inhibitors</z:chebi>, and improvement of microvascular perfusion with prostaglandine </plain></SENT>
<SENT sid="7" pm="."><plain>The increased anaesthesiological risk with these patients is due to the <z:hpo ids='HP_0011009'>acute</z:hpo> risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> and ischaemic cerebral and cardiovascular insults </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> management must provide stable perfusion pressures for cerebral and myocardial arteries and avoid increasing risk factors for <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> such as increased blood viscosity or stasis due to improper positioning of the patient </plain></SENT>
<SENT sid="9" pm="."><plain>The choice of <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> drugs is dependent on good controllability for haemodynamic stability </plain></SENT>
<SENT sid="10" pm="."><plain>The high risk of patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> justifies a more invasive haemodynamic monitoring and postoperative surveillance on an intensive care unit </plain></SENT>
<SENT sid="11" pm="."><plain>This case report describes the anaesthesiological considerations for, and management of, a patient with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> who was admitted to hospital for vaginal hysterectomy </plain></SENT>
</text></document>